These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29870744)

  • 1. Bioengineered intravaginal isolate of Lactobacillus plantarum expresses algal lectin scytovirin demonstrating anti-HIV-1 activity.
    Janahi EMA; Haque S; Akhter N; Wahid M; Jawed A; Mandal RK; Lohani M; Areeshi MY; Almalki S; Das S; Dar SA
    Microb Pathog; 2018 Sep; 122():1-6. PubMed ID: 29870744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-dengue virus activity of scytovirin and evaluation of point mutation effects by molecular dynamics and binding free energy calculations.
    Siqueira AS; Jerônimo Lima AR; de Souza RC; Santos AS; da Silva Gonçalves Vianez Júnior JL; Gonçalves EC
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1033-1038. PubMed ID: 28666874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin.
    Pusch O; Boden D; Hannify S; Lee F; Tucker LD; Boyd MR; Wells JM; Ramratnam B
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):512-20. PubMed ID: 16284525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression and purification of scytovirin, a potent, novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.
    Xiong C; O'Keefe BR; Botos I; Wlodawer A; McMahon JB
    Protein Expr Purif; 2006 Apr; 46(2):233-9. PubMed ID: 16289703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.
    Bokesch HR; O'Keefe BR; McKee TC; Pannell LK; Patterson GM; Gardella RS; Sowder RC; Turpin J; Watson K; Buckheit RW; Boyd MR
    Biochemistry; 2003 Mar; 42(9):2578-84. PubMed ID: 12614152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus.
    Garrison AR; Giomarelli BG; Lear-Rooney CM; Saucedo CJ; Yellayi S; Krumpe LR; Rose M; Paragas J; Bray M; Olinger GG; McMahon JB; Huggins J; O'Keefe BR
    Antiviral Res; 2014 Dec; 112():1-7. PubMed ID: 25265598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N.
    Liu X; Lagenaur LA; Simpson DA; Essenmacher KP; Frazier-Parker CL; Liu Y; Tsai D; Rao SS; Hamer DH; Parks TP; Lee PP; Xu Q
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3250-9. PubMed ID: 17005802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors.
    McFeeters RL; Xiong C; O'Keefe BR; Bokesch HR; McMahon JB; Ratner DM; Castelli R; Seeberger PH; Byrd RA
    J Mol Biol; 2007 Jun; 369(2):451-61. PubMed ID: 17434526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
    Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli.
    Pusch O; Kalyanaraman R; Tucker LD; Wells JM; Ramratnam B; Boden D
    AIDS; 2006 Oct; 20(15):1917-22. PubMed ID: 16988512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.
    Alexandre KB; Moore PL; Nonyane M; Gray ES; Ranchobe N; Chakauya E; McMahon JB; O'Keefe BR; Chikwamba R; Morris L
    Virology; 2013 Nov; 446(1-2):66-76. PubMed ID: 24074568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.
    Alexandre KB; Gray ES; Lambson BE; Moore PL; Choge IA; Mlisana K; Karim SS; McMahon J; O'Keefe B; Chikwamba R; Morris L
    Virology; 2010 Jun; 402(1):187-96. PubMed ID: 20392471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.
    Jensen SM; Ruscetti FW; Rein A; Bertolette DC; Saucedo CJ; O'Keefe BR; Jones KS
    J Virol; 2014 Feb; 88(4):2327-32. PubMed ID: 24284326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women.
    Lagenaur LA; Swedek I; Lee PP; Parks TP
    PLoS One; 2015; 10(4):e0122730. PubMed ID: 25875100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OAAH Family: Anti-Influenza Virus Lectins.
    Sato Y; Hirayama M; Morimoto K; Hori K
    Methods Mol Biol; 2020; 2132():683-693. PubMed ID: 32306367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico analysis of the cyanobacterial lectin scytovirin: new insights into binding properties.
    Siqueira AS; Lima ARJ; de Souza RC; Santos AS; Vianez Júnior JLDSG; Gonçalves EC
    Mol Biol Rep; 2017 Aug; 44(4):353-358. PubMed ID: 28756560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topology of the disulfide bonds in the antiviral lectin scytovirin.
    Moulaei T; Stuchlik O; Reed M; Yuan W; Pohl J; Lu W; Haugh-Krumpe L; O'Keefe BR; Wlodawer A
    Protein Sci; 2010 Sep; 19(9):1649-61. PubMed ID: 20572021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Engineered Microvirin Variant with Identical Structural Domains Potently Inhibits Human Immunodeficiency Virus and Hepatitis C Virus Cellular Entry.
    Shahid M; Qadir A; Yang J; Ahmad I; Zahid H; Mirza S; Windisch MP; Shahzad-Ul-Hussan S
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32054060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.
    Ñahui Palomino RA; Vanpouille C; Laghi L; Parolin C; Melikov K; Backlund P; Vitali B; Margolis L
    Nat Commun; 2019 Dec; 10(1):5656. PubMed ID: 31827089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Algal lectins as potential HIV microbicide candidates.
    Huskens D; Schols D
    Mar Drugs; 2012 Jul; 10(7):1476-1497. PubMed ID: 22851920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.